Patient and carer access to medicines at end of life: the ActMed mixed-methods study
- PMID: 35901229
- Bookshelf ID: NBK582221
- DOI: 10.3310/FIQE5189
Patient and carer access to medicines at end of life: the ActMed mixed-methods study
Excerpt
Background: Patient access to medicines at home during the last 12 months of life is critical for effective symptom control, prevention of distress and unplanned admission to hospital. The limited evidence suggested problems with different components of service delivery and, to the best of our knowledge, the impact of innovations in end-of-life service delivery has remained unevaluated.
Objective: To provide an evaluation of patient and carer access to medicines at end of life within the context of models of service delivery.
Design and data sources: The study used a multiphase mixed-methods design, comprising (1) a systematic literature review; (2) an online questionnaire survey of health-care professionals delivering end-of-life care; (3) evaluative mixed-method case studies of service delivery models, including cost and cost-effectiveness analysis; (4) interviews with community pharmacists and pharmaceutical wholesalers and distributors; and (5) an expert consensus-building workshop.
Setting: Community and primary care end-of-life services in England.
Participants: Health-care professionals delivering end-of-life care and patients living at home in the last 12 months of life and their carers.
Results: A systematic review identified a lack of evidence on service delivery models and patient experiences of accessing medicines at end of life. A total of 1327 health-care professionals completed an online survey. The findings showed that general practitioners remain a predominant route for patients to access prescriptions, but nurses and primary care-based pharmacists are also actively contributing. However, only 42% of clinical nurse specialists and 27% of community nurses were trained as prescribers. The majority (58%) of prescribing nurses and pharmacists did not have access to an electronic prescribing system. Health-care professionals’ satisfaction with access to shared patient records to facilitate medicines access was low, with 39% of health-care professionals either not at all or only slightly satisfied. Respondents perceived that there would be a significant improvement in pain control if access to medicines was greater. Case studies (n = 4) highlighted differences in speed and ease of access to medicines between service delivery models. Health-care professionals’ co-ordination facilitated the access process. The work of co-ordination was frequently burdensome, for example because general practitioner services were hard to access or because the stock of community pharmacy medicines was unreliable. Prescription cost differentials between services were substantial when accounting for the eligible population over the medium term. The supply chain generally ensured stocks of palliative medicines, but this was underpinned by onerous work by community pharmacists navigating multiple complex systems and wholesaler interfaces.
Limitations: Patient records lacked sufficient detail for timelines to be constructed. Commissioners of community pharmacy services and wholesalers and distributors were difficult to recruit.
Conclusions: Accessing medicines required considerable co-ordination work. Delays in access were linked to service delivery models that were over-reliant on general practitioners prescribing, unreliable stocks of community pharmacy medicines and clinical nurse specialists’ lack of access to electronic prescribing. Key issues were relationships and team integration, diversifying the prescriber workforce, access to shared records and improved community pharmacy stock.
Future work: Further research should consider policy and practice action for nursing and pharmacy services to fulfil their potential to help patients access medicines, together with attention to improving co-ordination and shared electronic records across professional service interfaces.
Study registration: This study is registered as CRD42017083563 and the trial is registered as ISRCTN12762104.
Funding: This project was funded by the National Institute for Health and Care Research (NIHR) Health and Social Care Delivery Research programme and will be published in full in Health and Social Care Delivery Research; Vol. 10, No. 20. See the NIHR Journals Library website for further project information.
Copyright © 2022 Latter et al. This work was produced by Latter et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution, reproduction and adaption in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/. For attribution the title, original author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited.
Sections
- Plain English summary
- Scientific summary
- Chapter 1. Introduction
- Chapter 2. Methods
- Chapter 3. Phase 1: systematic review and narrative synthesis of research evaluating medicines access experiences, influences and outcomes within end-of-life service delivery models
- Chapter 4. Phase 2: online survey of health-care professionals
- Chapter 5. Phase 3: case studies of service delivery models
- Chapter 6. Costs and cost-effectiveness of medicines access services
- Chapter 7. Phase 4: supply into community pharmacy
- Chapter 8. Phase 5: expert workshop
- Chapter 9. Discussion
- Acknowledgements
- References
-
Appendix 1. Systematic review: search terms for MEDLINE (
EBSCO host) - Appendix 2. Framework analysis cases 1, 2 and 4: patient/carer and health-care professional data
- Appendix 3. General practice: patient and carer sample
- Appendix 4. General practice: patient/carer interviews and log completion
- Appendix 5. General practice: health-care professional interviews
- Appendix 6. General practice: key service delivery descriptors
- Appendix 7. Annotated timeline exemplar: case 1 general practice
- Appendix 8. Logic model: general practice case
- Appendix 9. Patient/carer frequently encountered hurdles and delays in medicines access
- Appendix 10. Activity by other health-care professionals when the general practitioner is the main community-based prescriber
- Appendix 11. Clinical nurse specialist site: patient and carer sample
- Appendix 12. Clinical nurse specialist site: patient/carer interviews and log completion
- Appendix 13. Clinical nurse specialist site: health-care professional interviews
- Appendix 14. Clinical nurse specialist site: services provided by clinical nurse specialists, nurse independent practitioners and associated community-delivered services
- Appendix 15. Annotated timeline exemplar: case 2 clinical nurse specialist site
- Appendix 16. Logic model: community palliative care clinical nurse specialist independent prescriber case
- Appendix 17. Framework analysis case 3: community pharmacy-delivered commissioned services for palliative care
- Appendix 18. Medicines included in community pharmacy palliative care medicines schemes
- Appendix 19. Logic model: community pharmacy-delivered commissioned services for palliative care case
- Appendix 20. Telephone support line site: patient and carer sample
- Appendix 21. Telephone support line site: patient/carer interviews and log completion
- Appendix 22. Telephone support line site: health-care professional interviews
- Appendix 23. Telephone support line site: key service delivery descriptors
- Appendix 24. Logic model: palliative care 24 hours per day, 7 days per week telephone support line
- Appendix 25. Phase 3: data extraction form
- Appendix 26. Additional cost and cost-effectiveness tables
- Appendix 27. Phase 4: coding framework for community pharmacist data
- Appendix 28. Phase 4: coding framework for wholesaler/distributor data
- Appendix 29. Phase 4: characteristics of community pharmacist sample
- Appendix 30. Logic model of supply into community pharmacy: macro-, meso- and micro-level systems
- Appendix 31. Logic model integration of study findings across stages of the patient access pathway
- Glossary
- List of abbreviations
Similar articles
-
Access to palliative care medicines in the community: An evaluation of practice and costs using case studies of service models in England.Int J Nurs Stud. 2022 Aug;132:104275. doi: 10.1016/j.ijnurstu.2022.104275. Epub 2022 Apr 29. Int J Nurs Stud. 2022. PMID: 35667146
-
Supporting patient access to medicines in community palliative care: on-line survey of health professionals' practice, perceived effectiveness and influencing factors.BMC Palliat Care. 2020 Sep 24;19(1):148. doi: 10.1186/s12904-020-00649-3. BMC Palliat Care. 2020. PMID: 32972414 Free PMC article.
-
Clinical and cost-effectiveness of paramedics working in general practice: a mixed-methods realist evaluation.Health Soc Care Deliv Res. 2025 Feb;13(6):1-137. doi: 10.3310/GTJJ3104. Health Soc Care Deliv Res. 2025. PMID: 40022721
-
Reducing unplanned hospital admissions from care homes: a systematic review.Health Soc Care Deliv Res. 2023 Oct;11(18):1-130. doi: 10.3310/KLPW6338. Health Soc Care Deliv Res. 2023. PMID: 37916580
-
Digital First Primary Care for those with multiple long-term conditions: a rapid review of the views of stakeholders.Health Soc Care Deliv Res. 2024 Jul;12(21):1-68. doi: 10.3310/AWBT4827. Health Soc Care Deliv Res. 2024. PMID: 39056123 Review.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials